Fig. 6From: Identification of four metabolic subtypes and key prognostic markers in lung adenocarcinoma based on glycolytic and glutaminolytic pathwaysValidation of the LUAD risk assessment model. A Kaplan-Meier survival curves for patients at high and low risk in TCGA. B Patients of TCGA-LUAD were arranged in the same ascending order of the risk score. C Kaplan-Meier survival curves for patients at high and low risk in GSE42127. D Kaplan-Meier survival curves for patients at high and low risk in GSE72094. E Kaplan-Meier survival curves for patients at high and low risk in GSE68465. F Kaplan-Meier survival curves for patients at high and low risk in merge-GEO (GSE29013, GSE31210, GSE30219, GSE37745, GSE50081)Back to article page